CHICAGO– May 21, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced new appointments to the company’s global agency network, EVERSANA INTOUCH, to meet growing client needs.
Angela Tenuta has been named Global Group President, EVERSANA INTOUCH. In this elevated role, the 2025 MM&M Pinnacle honoree now leads multiple divisions under the agency umbrella, providing value-led marketing communications and transformation solutions for healthcare and life sciences clients. Under Tenuta’s direction, the Agency team has begun to deploy a new operating model focused on connecting strategy, creative, medical and omnichannel excellence like never before.
As a part of this new structure, John Kenny, PhD, has been named Chief Strategy Officer, EVERSANA INTOUCH, and will continue to oversee the agency network’s strategic planning team. Kenny’s work has been recognized around the world and across industries on global stages including the One Show, Cannes Lions and Grand Prix awards. Joe Wellington, MD, is now Chief Medical Officer at EVERSANA INTOUCH. He and his team’s expertise will continue to connect science, creativity and strategy for clients.
Additionally, EVERSANA INTOUCH continues to double down on its deep history in omnichannel excellence, and has added Daniel J. Gandor as Executive Vice President, and Head of Omnichannel and Digital Transformation. He brings more than two decades of experience to EVERSANA, having led similar efforts for leading pharma brands including AbbVie and Takeda. He joins an existing powerhouse at EVERSANA INTOUCH to further scale omnichannel excellence, content creation, delivery and deployment through TEDAVI.
“It’s a new era for our industry and prime time to elevate seasoned leaders within our award-winning global agency,” said Faruk Capan, CEO of EVERSANA INTOUCH and Chief Innovation Officer, EVERSANA. “Under Angela’s leadership and these key additions, this team is on speed dial for clients who share our heart for relentless innovation and greater marketing impact.”
In addition to these new roles, EVERSANA has also expanded its commercial team with several new hires who bring added industry intelligence and value to every conversation.
- Kathleen Ferry joins as the Executive Vice President of Network Growth, having previously worked at leading organizations including inVentiv Health, Fingerpaint and Klick Health.
- Kevin Coleman assumes responsibility as Senior Vice President of Strategic Development. Prior to EVERSANA INTOUCH, he held senior leadership roles at Edelman and Syneos Health.
- John Clarkson has also joined EVERSANA INTOUCH as Senior Vice President of Strategic Development. He’s held senior leadership roles at organizations including Havas Health and 21 Grams.
“No other agency, large or small, can match our experience in omnichannel, creative, strategy and science while also understanding how it all connects with commercialization services like patient services, deployment solutions and data and analytics we can deliver as part of EVERSANA to ensure our marketing strategies drive brand value and client success,” said Tenuta.
EVERSANA INTOUCH is an eight-time, pharmaceutical agency of the year winner, a top 10 pharma agency for six years and counting by industry publication MM+M, a Great Place To Work winner for six consecutive years, and one of the most creatively awarded healthcare agencies in the world. In 2024 alone, EVERSANA INTOUCH garnered more than 60 wins and recognitions, in categories including social responsibility, craft, philanthropy/purpose-driven work, health equity, experiential, consumer, healthcare professional, social media, video and innovation.
Tenuta was also recently reelected as the Central Region representative on the American Association of Advertising Agencies’ Board of Directors. Additionally, EVERSANA was awarded an AI Excellence Award from the Business Intelligence Group for the third consecutive year, building on the organization’s reputation as a leader in commercial innovation.
About EVERSANA®
EVERSANA is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.
About EVERSANA INTOUCH
EVERSANA INTOUCH is a global, full-service marketing agency network serving the life sciences industry, and is the first – and only – agency network to be part of a fully integrated commercialization platform through EVERSANA. EVERSANA INTOUCH provides marketing services – connected and powered by data-rich, digitally forward analytics – through its full-service and specialty agencies: EVERSANA INTOUCH Solutions, EVERSANA INTOUCH Proto, EVERSANA INTOUCH Seven, EVERSANA INTOUCH Oxygen, EVERSANA INTOUCH Engage, EVERSANA INTOUCH Healthware, EVERSANA INTOUCH Tech & Transformation, EVERSANA INTOUCH Media, EVERSANA INTOUCH MedComm and EVERSANA INTOUCH Market Access. To learn more, visit eversanaintouch.com or connect through Facebook, LinkedIn, X, or Instagram.